Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most ...
Jul 21, 2023
0
11
For patients with HIV without genotype information, a second-line switch to dolutegravir is noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI), according to a study published in the June 22 issue ...
Jun 23, 2023
0
2
For Black patients with HIV on antiretroviral therapy (ART), those who switch from efavirenz to dolutegravir gain more weight and have an increased risk for hypertension, according to a study published in the March issue ...
Mar 21, 2023
0
2
Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by Harvard T.H. Chan School of ...
Aug 31, 2022
0
61
A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to a global trial led by researchers at UCL.
Dec 29, 2021
0
99
An observational study found that gender/sex disparities in the use of dolutegravir-containing antiretroviral therapy (ART) persist despite World Health Organization (WHO) endorsement for its use among women with HIV of reproductive ...
Nov 30, 2021
0
3
Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests new research published on World AIDS Day. The study finds that this so-called 'wonder drug' may be less ...
Dec 1, 2020
0
28
A new study by UBC researchers is set to change international treatment recommendations for people who are newly diagnosed with HIV—an update that could affect nearly two million people per year worldwide.
Oct 16, 2020
0
0
Children living with HIV can now benefit from an adapted, simpler combination therapy. In combination therapy, two or three medicines are used simultaneously to inhibit HIV. One of those agents is dolutegravir. Thanks to ...
Aug 4, 2020
0
3
Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other antiretroviral drugs. The ...
Jul 22, 2019
0
1
